Back

Evaluation of primary prevention ICD efficacy in late elderly heart failure patients: a multicenter study

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Heart failure prevention: pharmacist-led guideline-directed medical therapy and training Implantable Cardioverter-Defibrillator (ICD) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Akiva Brin

Shaare Zedek Medical Center, Jerusalem (Israel)

6 More presentations in this session

Presentation thumbnail
Oral ferric maltol in heart failure patients with iron deficiency anaemia according to NYHA functional class
Doctor W. Geller (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Association of an early multidisciplinary HF pathway and inpatient rehabilitation with 1-year survival: a four-group real-world analysis (2020–2025)
Doctor R. Fujimoto (Tsuyama, JP)
Abstract Slides Video
Presentation thumbnail
Inpatient-initiated and home-based exercise training reduces heart failure hospitalization and reverses frailty: a prospective randomized study
Doctor K. Kim (Incheon, KR)
Abstract Slides
Presentation thumbnail
START-HF: a multi-centre evaluation of centralised pharmacist-led remote GDMT optimisation in HFrEF
Doctor A. Kirupananthavel (London, GB)
Abstract Slides Video
Presentation thumbnail
Trends in utilization and clinical outcomes of sodium-glucose co-transporter 2 inhibitors in patients with heart failure undergoing mitral transcatheter edge-to-edge repair
Doctor A. Qamar (Chicago, US)

Access the full session

Session thumbnail
Heart failure prevention: pharmacist-led guideline-directed medical therapy and training

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF: pro
30 August 2025
thumbnail
Congress Presentation
Adaptation of the Charlson Comorbidity Index for risk prediction and implantable defibrillator decision making in the older adult
13 April 2026
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator therapies in primary prevention are not decreased in a contemporary cohort: insights from long-term follow-up
1 April 2025
thumbnail
Congress Presentation
All-cause mortality in post–myocardial infarction patients with reduced LVEF with and without ICD therapy: insights from the PROFID study
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources